Trends in Research Payments From the Industry to Dermatologists

Between 2015 and 2023, 1,610 dermatologists received a total of $1.44 billion in research payments, with an average of 84% directed to NCEs with a dermatologist PI. Research payments to NCEs with a dermatologist PI declined from $161.0 million in 2015 to $107.6 million in 2023, but the overall trend was not statistically significant (p = 0.27). The top 10 NCE organizations received $179 million, with most being private institutions involved in pharmaceutical clinical trials. Four pharmaceutical companies accounted for nearly half of all research payments. Conclusion: Most research payments from the industry to dermatologists originated from a small number of pharmaceutical companies and were directed to NCEs, which have minimal reporting requirements. These findings underscore gaps in transparency within the OPP and highlight the need for new disclosure requirements regarding the distribution and use of funds to NCEs.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-10-17
DOI
https://doi.org/10.7759/cureus.94824
Primary Topic
Pharmaceutical industry and healthcare
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends in Research Payments From the Industry to Dermatologists

Bruce J. Trock, Joseph Cheaib, Gerard F. Anderson, Zhuo T. Su et al.
Cureus
Pharmaceutical industry and healthcare
article

Trends in Research Payments From the Industry to Dermatologists

Bruce J. Trock, Joseph Cheaib, Gerard F. Anderson, Zhuo T. Su, Aurora J. Grutman, Zeyad Hammadeh, Misop Han, Carmel G. Cronin, Aleksandra Drmanovic
article en

Abstract

Between 2015 and 2023, 1,610 dermatologists received a total of $1.44 billion in research payments, with an average of 84% directed to NCEs with a dermatologist PI. Research payments to NCEs with a dermatologist PI declined from $161.0 million in 2015 to $107.6 million in 2023, but the overall trend was not statistically significant (p = 0.27). The top 10 NCE organizations received $179 million, with most being private institutions involved in pharmaceutical clinical trials. Four pharmaceutical companies accounted for nearly half of all research payments. Conclusion: Most research payments from the industry to dermatologists originated from a small number of pharmaceutical companies and were directed to NCEs, which have minimal reporting requirements. These findings underscore gaps in transparency within the OPP and highlight the need for new disclosure requirements regarding the distribution and use of funds to NCEs.

CureusVol. 17(10)
Johns Hopkins University (US), Johns Hopkins Medicine (US)
Arnold Ventures, Centers for Medicare and Medicaid Services
Openalex Percentile: Top 62%
Pharmaceutical industry and healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.